“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

If you don't feel hungry as much as you used to, or you are not wanting to eat as much food as you would usually, this could ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

A 14-gene molecular assay could help predict which patients with early-stage non-small cell lung cancer will benefit from ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

summarize the emergent understanding of molecular subtypes of small cell lung cancer (SCLC ... monitored by serial liquid biopsy-based biomarkers, will be needed to improve the outcomes of ...

Patients with extensive-stage SCLC often respond to induction therapy, but the disease tends to progress rapidly after cytotoxic therapy ends, said Jared Weiss, MD, of the University of North Carolina ...